Researchers continue to excited about this new drug, a novel dual treatment showing promising outcomes in early trials for body reduction . It acts by targeting several hormones : GLP-1 and GIP, that , when stimulated, support influence hunger and improve energy expenditure . Preliminary reports suggest substantial size loss and potential improveme